Rev.
Inst- Med.
tro|.
São paulo 2g(5) t276-2E3, seteñhrò-outubro. lg87PREDICTIVE VALUE OF SEROTOGIC IESTS
IN
THE DIAGNOSÍS ANDFOLLOI¡V.UP OF PATIENTS W|TH PARAGOCCIDIOIDOMYCOSIS
tr)
Luz EIeD¡ CIINO & Á[getÐ BESTA,RO
A
serologic study was undertakenin
a gtoupof
4A patientswith
active pelacoscidioidomycosis who were treated
in
the samefoÍm
(ketoconazole). fo¡identicaJ. periods
of
time (6 months), and followed-upfor
valious periods post. therapy. The tests employed w€re agar gel iÌnrnunodiffusion (.A,GID) and, com: plement fixation(FC).
AIso studied were S0 setafrom
patients ,with provenhistoplasmosis and pulmonary aspergilloma, B0 patients rwith culturaly proven
tuberculosis as \¡¡¡ell as 92 specimens from healthy individuals, residents
in
thg endemic a.reafor
pamcoccidioidornlrcosis,A
singlelot
of
yea,st filtpàte antigenwâs used throwhout the stud¡r,
ltre
va,lue of each tÆst was measuted acsordingto
GAIEN a¡rd GAMBINO6.
Both tests v¡ere highly sensi¿ive, gg aÃd. gtVo rcs. tæctively. Regarding their specificity, the AGID was totally specific S¿hile theCI'
edúbited 96.6Vo and 97qo specificiþin front of
tuberculosis patients and healthy individuals respectively and. 82%in
comperisonï'ith
patients with other mJ¡coses. The concElt of predlctive value, that is, Ûre certainty one ha.sin
accepting a positive test ås diagnostic of paracoccidioidomycosis, favored tbe,q.GID proædure (70OVo) ov4-r the CF
test.
The lattet coutdsort
out vnllr- 9t7o ceftainty a patient with patacoccidioidomycosis among a groupof
healthy indi. viduals a,nd willf, 97.5%in
the saseof
TB patients; when the groupin
questionwas (877a). composed by individuals with other deep Í\ycoses, sucTì certBinty was lower
T'he above results indicâte that both the .4,GID and the CF iests fumish results
of
high sonfidenc€; one shouldnot
telay, howevel,in
the CF alone as a meansto
establish the specific diagnosisof
pamcoccidioidomycosis.KEI¿ WORD,S: Predictive values; Serologic tests; pamsoccidoidorlycosis; Cros$
rea.ctions; Systemic lr¡ycoses,
SUMMABY
ParacoccidÍoidomycosis irs
a
polylno4lhio disease andits
varying clùúcal manifestationsoft€n delay promp¿ consideration by the trea-ting physical of its real etiology.
In
tffs
con_ text serologic tests play an important role indiagnosist"2,11,u,17,19,25, FΡrthermore and due
to
the ch¡onic natureof
paracoccidioidoh.vcG sis, such tests are also cruciâlin
evatuatingthe patient's respo¡ìse
to
treatme¡;it 2.as,2,8p4,(') s¿udy ges€ntod durj¡s the rslt¡M rr¡temãtlotrsl cou(ql¡IuE on psrêcocclauoidomycosis, Ileb¡1¡sry t986, M€de¡ü¡,
eo-loÍrbiB.
cotpo¡ación !3¡a lnvestlgactones Blológic5s (cIB), qoslitÀt p¿blo l¡obóÃ urtbe, Mectellin, cotombts, south ¡t¡¡rer¡cs.
INIT,ODUGTION
This being so,
it
worrld bs highly deslrâbleto
attempt standatdization
of
the
various tests currently available andof
the
reegents erE,ployed
in
such tests s,7.cenetally,
in
o¡derto
achieve standardlza,tion,
it
is necessårf,r to r¡ndertake the-statist¡ca¡ anâlysis of the most p¡omising tests 6,2,10.Ihg
CÁNO, f,. E. & RESTREPO, A. - Èedictive value of se¡orogic tests in the diaglþsis and fotlo\¡¡-u! of pEtionts ìrith
pa¡âcoccidìoidomycoE:s. Rev. IDst. M€d. irolr. São P¿u¡o, 29t 276-2A3, 1987.
tests results obtained when studying series of patients ând
of
controlindividuals.
We be-lievethat
various points should be empha,si-z,ed here as follqws:1.
The group(s) ur¡del study should beas homogeneous a,s possible and cons-tituted by p€$ons twith simila¡
charâÆ-teristics.
Ideauy, Û1 the caseof
pa. tients-
rwho should have been prc. perly diagnosed-
tåey should beacti-ve ât time
of
filst
testing, be treatedwith the
same drug andfor
similar periodsof
time, q'ith bleedings ta,lring placeat
identical pe¡iods during and after therapy. Healthy controls should be chosen among persons living in theknown endemic areas
for
the disease urderstudy.
Patientswith
ot¡rerfi¡n-gal
diseases shouldalso
be
studiedonce their diagnosis has been propedy established.
2.
Identica'l tÆsts should be applied to aü specimeru! and the methods sl¡ould be carefully controlled, avoiding modifica,tions
to
the teshniques during the peIiod
of
study7 6.3. It
would be highly desirableto
use asingle
lot ot
antigenfor all
tests butif
thisis
not feasÍble, one should em-ploy antigens of comparable potencyT'16.Ihe
above steps twould, eliminat€ va,riables and would peamita
more precise statistical evalu&tion.I̡ring
the pa.st 6 years rwe have had tl¡eoppofiunity
to
perform serologic teststo
a seriesof
patients and healthy coDtfol groups who present optimal conditionsfor
standardi-zation. The results we obtained form the ba. sisof tllis
publication.MATEßIAL ÄND METIIODS
Sera obtained
from
4
grol¡psof
percons were studied" as follows:G¡oup
À:
Composed ttJr 43 pa,tients \trithlaboretory proven parasoccidioidornycosls as
described elsewhet e T'n þE,
Group B: Fo'rmed þy 50 patients vrith othe¡ deep mycoses, lwhose diagnosis had allso been
established b¡¡ laboratory þro¿€dures. There
were 33 cases with histoplasmosis and 17 vrith pulmonary aspergilloma.
Group C: Constituted
by
30 patients with culturally-proven tuberculosisby M.
tubercu.losls var, hominis.
Group
D:
Composedby
92 healthy indivi. duâls,all
residentin
endemic a¡easfor
par€"coccldioido[rj¡cosis and v¡ho had been previou&
ly
skin-tested with paxacoccidioidin and for¡ndreactive æ.
Concefnturg group A, tftese patients were
exarniried at various periods.
All
43 v/ere tes-tedat
timeof
diagnosis, whentheir
disease wasactive.
They v¡¡ereall
treated vrithketo-conazole (200 mg,/dey)
for
a periodof
6mon-ths;
duringthis
time, 42 patients wet€ bledat
montl¡3 of
thempy and4l
at
6
months, Upon determinationof
therapy, 31 patientswere available
for
testi.ng 12 months after fi-nishir¡g drug inta,he, 16 patientsafter
24-and
I
after 36-
months.Patients with paxa.coccidioidom¡¡cosis wer€
classified
as
having pulmonary diseas€ withdissemination
to
othet organs (29, 67 -ïEo, otas
presenting involsement lestrictedto
thelungs (14, 32-5Vo)
-
Concwrcîf, pulmona"rJ¡tu-berculosis was found
in
5
patients (11.07¿).Regarding other parameterc, most patients (42) wele males and
âIl
were adults, ages 35-62 yeals.Sera were collected before breakfast f¡om
all
individuâls (groups A, B, C, D), prese¡ved\trith 1:10.000 meÉhiolate
in
bu.ffer solution 8,and kept
in
the æfdgerato¡ at 4'Cuntil
timeof
testing; this rwas done before 15 days of collection date.The serologic t€sts evaluated
ï'ere
com. plement fixation (CF), the 50ø¿ hemo$¡sismi-crGtest recoûlmeded
by
the CDC Laboratorl¡Brar¡ch e, and
tfie
âgar gel immunodiffusion techrique (AGID) suggested by the Panameri.ca'n Health
Organization serolog¡¡ study grou¡x 8.Both tÆsts employed .a yeast
filtrate
ánti-gen obtained according
to
techniques alleadydescdbed 23, from P. b¡adliensls isoþte 8339.
c'aNo' pâEcoccidioidomycos:s. L' E & RESTREPo Rev. A - IDst. Pre'lictivs Yslue of serotoglc tests tn the diasÐosis sn¿r folloey..up of lauênts with
Med. tlop. São p¿uro, 29: }?6-283. I9B?.
For
comparison putf)oses,a
single¡ot
of Histoplasl¡La capsulatum whole yeast oells a.ntigen \Ã'as prel)âted ¡5 and used in the CI' tests. CF results werc considered positive when
the titer
was>
1:8; IDGA results qrere DG Êitive when band 1 either aloneor
accompa. nied by bands 2 and g, q'as detected 1?,1s.St¿tistical analS¡sis eacompassed thè deter_ mination
of
sensitivity, especificitr anal pæatic.tive
velueas
definedby
GALEN and. GAM-g1¡9o, and
ITOZINNand
TASCIIDIIÂN r0 (Table1).
Tlre Studentt
test was used to de_temine
statistical significance.?ÅBLE 1
D€f¡nitioÌì of teIÃls (+)
ooncePt
30 TB patients GsVo) as well as B of the
nor-mal
controls (3.37¿), tumed out positive.When the
IL
capsulatum whole yeast cellsantigen was used
in
tfìe C¡' test (Fig. 1), at¡ histopla.smosis sel6r reâcted; a high proportion G7 or 86Eo) of the para,coccidloidomlrcosis ca, ses also tecogn¿ed ttre heteÌo,logous antigen. S€ven serum samplesfrom
aspergilloma pa.tients
(
þqo), oneof
the TB patients (8.32¿) andI
from the healthy control group (9.8%) werc also positive.ïhe
sensitivity of botll serologia tests wasdetermined
in
trmtientswitf¡
para4occid.ioido-myoGsis, a¿ every one of the study perioals (Fig.
2).
At
timeof
diagnosis both AGID ar¡d CF proved highlt sensitive (Bg ând g0Z¿)æsDecti-vely.
lherapy caused.a
certain lossoi
sen-sitivity
with
â
trend towardsloweÌ
figuresráith time
of
thempy.At
the endof
J yeâ.ßalter
cessationof
treatment, AEE, of.lhe
ca,-ses could
still
be detected by AGID and 85Zoby the CF: IIowever, ¿here were no statistical
differences betrween the two tests.
The sf,ecifìcity was determined
in
thecon-trol
gÎoups(8,
C andD).
.q,s eai] be seenin
Fig._3 the AGID test was totally specific, ,ì¡,iû¡ no false positive reactions being recorded forpati€nts
with
other myoosis, tuberculosis or healtl¡Jr controlË. .A,sit
lærtains the CF test (Fig. 3), only3
false positive reætions (g7Eo specificity) were recordedfot
the healtùJrcon-trols, one
for
the TB patients (96.62¿) andI
for
the group of patients with histoptasmosisand aspergilloma (gZZo
specificity).
Ihe
dif-ference between healthy controls, and pâtients which other mj¡co,ses was statisticaltlr sigt¡i. Sensitiyttt percentage ot
dlse8se i¡dtir4aluah
qriüh positivo test
æsults
Speclftcitj' percenktge of non-diseased individuåls
Ì\¡ith negative ¿est results.
k€dicttye percen¿Bge of
v¿Iue of s lositive reactols positive test having disease
D€ftnftioE Equation employed to meâsure vhtue of test
(+) TaI€n from cât€n ânat Gambioq ^ ,.rìar r<ozjnn ar; T,P. '
T.P.+IlN...
T.N. r.'
---_x100
T.N. + P.
T,P. _--X¡OO
T.P. +FP. *i.*
T¿schdliÂû ro.
Disease plesent: . T. p. = t¡ue postLrvo ¡eac¿or
'. I¡. N. : tâlse negårive reâcto¡
DiseÀse absent: .¡* ..** T. N, = true negåflv€ teâcrot
F. p.: Jalse positrvo rcaøor
RESIJLTS
I'igute 1 sr¡mmarizes the reactivitJr
of
thetwo tests employed.
ft
can be obs€rved thatin
the
AGID positive æsults were obtainedonly
with
patients \4'Íth paracoccidioidomyco. sis (group A'),38 (BB.4Vo)of
whom p¡oduced precipitin lines ,withp.
bmsitiensls antigen. Patientsq'ith
other mycoses, tubercì¡losis and healttry conttols \áere nûn-rea.ctive.Conce¡ning
cF
test (Fig.t),4i
@Bqù of.group .4. patients also reacted to p. br¿silietrds
yeast antigen; hete, however, sela from other
groups also proved reactive. Eight
of
the BBpatients with histoplasmosis (2S.SEø),
I
of
tlfte17
with
aspergiloms (S.BVù aDd. oneof
thofisant(p=<0.01).
ConceTning the ptedictive value
of
a Dosi. tive AGID test (Fig. 4), suoh a value was tìr07o bothin
telation to the healthy controls and to the patients wíth either TBor
r¡ycoses diffÊrent to paracocqidioidosrycosis. As
for
ttre CFtest its prediotive value in relation to tlre
heal-thy
control was high (qgEò: sucr¡ a value di_ minlshed dudng andafter
treatme¡tbut, Ít
is stilt of 73Eo
^11æ 86 months of therapy ces.
sation.
In
relationto
the groupof
patients\pith
other mycoses,the
prcdictive value of the CF test at dlagaosis wa.s lowe¡ <gtEo, tf¡anthat
for
healthy controts (gT/o) andTB
Da'tierúf <97.57or. AfteÌ therapy, t,Le value decrãa
sed steadely
to
rcach SOlo at 86 monfirs DostCANO, 1,, E, & REST.REPO. .{. -¡P¡edictive value of serologic t€€ts in tho di8g[osls a¡d fol¡ow-up ot p¿tieÈts vltD
p€¡8¿occtaltotaloE¡¡cosis.
' Bee, IDsÉ. Mert- tÉp. São Pd¡lo, â. nÈW, 198î .
Groups
m
PorococcidioidomycosisI7--
H¡stoplosmosisI
Pulmonory Aspergillomo Ef:f:tl TBIf
Heolthy controlsFig. 1 - Semrogic test¡¡g with P. Dmsulensls arld lI. cslFul¡tum ÂDttgenE in patients with systemic Eycosês, tubercutosis
and nolmal pe¡soDs.
Agor gel
irnmunodiff usion (AGID)
w¡th porûcocc¡d¡oidin
Itre
resultsof
t̡e prcsent study confim lrevious indications concemingthe
adequate sensitiviw of both tåe .6.GID and the CF testsfor
the
dt8€nosisof
pamÆoccidioido4lrcosis 1,34;6).1,,12,t314,17'23,27. Concernlng tl¡e specifici. Wof
such tests, our results offer statisticaüJrsupported datå
for
the AGID, former¡J¡ shown to be highly specific 3¡,8,ú,13.2¡.In
ttris ægar4the
cF
test atthough l¡ighly spec;fic (g'IEo) in front of healthy controls, tsas shoen to be lesspreûise nrhen cornpBred
to
patlentswÍth his
toplasmosis and aspergiUom¿(82øo).
îress tEo mycotic dlso¡ders are collrmonin
the en demic ar€asfor
pamcoccldioidomõ¡cosis 5r6gtand,
itr
consequence, one mayrim
lnto
düfi-culties !Íhen &tt€mptinga
defiDite d¡agnoslgl¡r a pafticular pattent,
Se8rching for Ê mef,hod to cledry the abo
vo problem, we have utillzed a ststigtical
coD-cept, tbat of tha p¡edlctive ìsatue
of
a positlveDISCUSSION
Complemenl Fixofion (CF)
with porococcidio¡d¡n
tÈ5tJ ì
vr¡lh U:ggplglgrul! whole
teost cells
test ånd applied
It
to
paracoccidioidoÍSrcosis.ï1lis
concept advancedby
GALEN andcAM-BINO ó, furrishes
a
more precise inforD¿tio¡ concerningthe
possibilitytbât
a¡¡ individual who has rea€tedin
t,lle test,truly
has pam,coccldioÍdom!¡cosis.
Ibe
results iDdicate tbats
serum reactivein
the AGID fest should comef¡om a patient who has
-
ot
has had-
paÊmcoccldioidomycosis,
The
certainty
comesffom
the 1007¿ prcdictive values exhibited by this technique eitheÌ at the tllneof
diagnosisor
et
var¡ous pelioals dur¡¡g and after thera.py.
In
tl¡e caseof
the CF test, a posiuvete
silrt
in
arl und¡agûosed pati€Dt inaUcates tbøtin
comparison witf¡ hestt\y inauvidualsin
theeDdehlc aleas,
tl¡is
patient has 937¿possibl-lilies
of
llaving paÍacoccitlioidorqycosis; this is also a meaningfulflgure.
tlowever, a¡nong âpolrulation Of patients \tr¡tlx suspected ll]ycoses,
tåe
Ofs
pÉdict¡ve value.is
lower @!qo) etrtd althóughnot
yet
€xtrcmety ùnþofta.nt, theret,
CATYO, L. E. & R;ESTREPO, A. - P¡€dictive v¡ilue of seÌoloAic tests ir the aüâglosis a¡d fottow-up of pati€nts wtth
pamcoccidioialoevcosjs. Rev. IDst. Med. trop. São Psr¡lo, z9t 276-283, 19A7.
i.
I;
'õ
ô-àe
a¡ararrrìotl
L Diogno.i. ond rtreropy J
¡'ig 2 - Sensit¡vity oI s€¡ologic tests with P. brasiließis súige¡s t¡ patieDts with paÈcoccictioiatomycosis þeto¡e, duliûB s,nd afteÈ slecific the¡e?y.
illness,
.Asit
pertains tuberculosis, thepre-dictive va.lue was lrigh (925/or, tnùcatì¡lg
*øt
the t€st is capable of discrird¡ating wilh high efficienclr bef,ween this drsotder and paracocci. dioidorqycosisr.ff
treatmentfor
tho mycosesis
offered, the prcdictive velue deüeases anal after 36 monthsof
therapy cessation, the pos-sibiutiesof
colTectly deternjning tlre etiolosrof
the paat. illnessis
only 5080.fn
some diagnostic centers,it
has b€€[¡ costumary to perform botl¡ the AGID andtlþ
CF tests because thefonrer,
¿lthough muchsimpler
to
perform, does not vaqr enterisivelJrduaing the follow-up studies, while Ure latterr
procedu¡e lenals itseLf to adequ¿te quantitifica"
túon.
Ibe
rcsults we p¡esent hero indicate th¿tit
is
stiu
sowrdto
proceed atong such lùres. Cross reactivibr amoDg varior¡s n¡rcotio antigens has been exteÐsivet!' docum¡9nted ü¡ tåe past 35.13,15¡BÆ,28,with
tlrellore
sensitivêteshniques caflryiag the lerger burden of noû.
L
Perio¿. of Observot¡on ( Months)J
I
Post - Th eropy
AGID
spesificibt,ó,21. Cleârly there is need to studJ¡
the antigenio make up of P.
brrs
ieDsis and ofother mycotic agents causing deeÞseated
Í\y-cosis
in
otder to isolate specific antigeniomoi-ties. fn
this
folm.,it
B'ould be possibloto
prcduce specific ant¡gens whic.l¡ would ft,srilt
tn
t€sts ü¡ith higlrer predictlve values a,ûdj¡
a
more prccise diàgnosisfor
the patientl¡
need
of
ploE¡tt, specific theraly s,?8.RÐST'MEN
Valor pledisffvo de
las
Inuebas serofodcss Irara el dlagnosdco y seguimtento de IaIla¡æorcialtoidomicosls.
Con
el
objeto de determinarel
vdlorp¡a
dictivo ale las pn¡ebas serológicas (F¡jacióD doComplemento, trE,
e
fnmunodlfusió¡e[
cel
de
Agar, IDGA), utilizaalas ¡egulaFmente €r¡ nuestro laboratorir ¡)arael
diagnósticoy
elSANO, !. E. & R.ESTR¡IPO, A. - Preillctive value ot s€rologio teÁhs in the drãgaostB a¡d follow-üp of pstr€nts sith
Bev. LEst, lvled. trop. Sio Pr{o, Æt È18.2æ, 19A7.
.;
à!
Groups
Fig. ¡ - S!êcificity or se¡orogic t€sts reith P. brl¡ rersû ÀntigeDs in fhlee ditte¡ent controt smups_
Grougs
æl
Heolthy cmtrolsrEsr
_____J
Ø
Polienls with hisloplqsmos¡sond osperg¡llomo
I
Poti€nls with TB60
.:
= fL^40
036
L During
f."ot."nt J
Eig. 4 - Pr€diclive calue ol ð positùe serologic test tn p¿tients with para{occldioidoll¡¡¡coâis atrd ià t¡æe d¡tfeft'at
conü¡oI Bror¡ls, acco¡ating to tine of t¡rerapy.
AGID
L
Pêriodof
Obs€rvol¡on (Uont¡slJ
.'.'.
Heollhy conlrolsr¡rl
TB pol¡€nts-
Pqtionts other
mycoseS
CF
72
cÂNO, pâmcoccidioidonycos:s. I t & RESTREPO, nev. IDst. Med. trop. A - Pr€dlctive lalue of se¡ologic tests iE the altBglosis å¡at fotloF-r4r of Þsti€ûts wità Sio Psuto, nr y¡6-Z&3,79A7,
anaJizaron los datos Þrovenientes de 43
pacien-tes son
la
enfermedad. Tales pacient€s fuerontratados en forma identica (Ketoconazol, 200 mg/dia por 6 meses); además ambas pruebâs serológicas utilizaron un mismo lote de antig+ no, eliminando asl posibles variables. FU€ra de los sueros provenientes de los 43 pacientes con paracoccidioidomicosis (¡{), se estudiaron 50 suercs de pacientes con otrâs micosis
pro-fundas (B)
y
92 sueros de personas sar¡as (C). Empleamos las fórmula,s dadas por GALEN yGAMBINO ó
y
hallamos que la sensibiltdad de ambas pruebas serológicas era comparable, sindjferencia estadísticamente significativa entre
ell8s (FC
=
E7,IæA
=
88AVo). Dicha seû sibilidad tend.Íaa
disminuir con eltratamien-io,
siendo más marc¿da su baja du-rante lasobseúsaciones post-terâpia. .Al a'nalizar
la
egpocifibialad se enconttó que
la
IDGA erato-talmente esp€cífica,
no
encontrandqse falsospositivos en las poblaciones controles estudia,
dâs
(B
y C).
La
F'C mostrów
S6.7Eo de especificidqd frentea la
poblaciódC
y
un 82Eo trenl,ø a la B, siendo estedistisarnente sig-nificativala
diferencia entre ambas. Basados en los datos ariterior€s, se buscó et valofpte
dictivo, hallaridose quela
IDGA d¿ seguddâdcompleta para el diagnóstiso en cualquiera de los perfodos evaluados
no
asila
Fc,
la
que mostró disminución de tales va.lotes durante la te¡apia y la post-terapia. La cl¡Iva æspèctiva mostró como a medida que pasaba eI tiempo,disminuÍa
la
posibiildad de diferenciarla
pa.ra,coccidioldomicosis (.4.) de otra,s micosis (B), manteniendose, sinembargo,
Ia
diferencia con los controles normales (C).AqINOTÍLEDGEVIEl{T
T'lre authors Ð<press their appreciatton to
the patients for theit constånt cooperation and
to
Dr. William Mejfa' \¡¡ho kind¡y checked thestatistical analysis.
REI'ER,ENCES
P. bm€lue¡¡si,e lÌEeu¡odiJtusioD test an geE. J. cüi.
Mic¡ol¡lol., 19: 40+407, lSa4.
4. FAVA-NETTO, C. - trlùnu¡ologia da para¿occidioido-micose. Rêv. IreÉ. l}f€at'. 1rop. S. p¿ûIo, lE: 42,53, 1926.
5. IEAiRETIIÌA-CI¿UZ, M. F.; GAI,VÁO_C¡îSTRO. B. & 'WÁNù(E, B.
- PÐdução ê f,âdronização dos anttgenos ¿lo P. b¡âsilieÉ¡s, II. c¿psulðtum, A, f¡utg¡tus perÂ
uso no tmúroaliagróstico. Mem. IDst. Osw. Cruz, t¡:
301.305, 1985.
6. GALEN, R.. S, & GÁMBINO, S. R., ed; - Beyond
noÌrÌ¿tity. Tlrc prcdÍctive f¿tue and efflci€ú(t of me-atic¿l diagnosis. New Yorik, J. Witey ê!a! SoILs, 19?5,
p. 10-14.
7. EITEPEET, M.; SUN, S. H, & VUKOVICII, K. &.
-Stanai,a,rdÞâtlon of Сrcotodcat rcagents! In: INTffi-NATIONA¡. CON¡EEENCE IN STA¡ID¡IR,DIZI\TION.O¡' DL{GNOSTIC MATBIAL. proc€ed¡¡€!, A a¡ta, C€dteß
fo¡ D¡s€asè Coltml, 1974. p. 1A7-794,
8, KÅT'FnlÂN, L.; HÛPPER,T, M.; FAVA.NSITO, C,; NE. GRONI, R,, & IIESTREFO, A. - ltanual of stanat¡¡dized
serodiatnostic pmcedües foI systêrEtc ûycosis. part I:
Agar gel iEEu¡oaliffuston tests. Washt¡gtÐn, D. C., pa-aÀnêdcar¡ H€etth OrgaÀizstion, 19?2¡
¡{AIrIllf¡ArN, L.; EUPPEET, M.; FAVA-NSI:IO, C.; NE-GI¿oM, R,. & RESTRPO, Â. - MarìÌ¡sl of stêndâdized
serodlagnostic procedu¡es lor syst€mic mycosis. pa¡t I]:
€oEplêmert fixation test. Wasrdngtôn, D. C,, pâ¡s-mericrü H€slth Organizetion, 1072.
¡<OZ¡NN, P. J. & T¡ISDCII.IIAN, C. L. _ I¿boBtor]¡
auâg¡osis of cåndldtÀstS. In: BODqr, c. p. &
FAINS-TEIN, V., €d. - Cåral¡{¡¡âds. Neer york, Rsv€o p¡s€s,
1985, p.85-110.
LONDERO, A. T.; I,o¡ES, J. O. S.; E.qMOS, C. D. & SEI,IERI, L. C. A pmva alå. dup¡a atifus.eo €m get
de sgar no auâgnósüico de pa¡acoccidioidoEicose: Bev.
As$c. md. Bro C¡. Sol, | 272-n5. lSAt.
M¡IITINS'SIQIIEIRA, A, - Dtqnóstico tEÌ¡¡ológico. In: DEL NEGRO, c-t LACAZ, C. S. & ¡TORIIÃO,
A, M., €d. - Par¡coccLliolrtomtco€e. Blasto¡dcoÊ€
sì]l-å¡!e!ics!a. SÉo laulo, SElvier; EDUSP, 19A2. p. A-æ4.
MCGOWAN, ¡(. ¡. & ÈUCKELY, lI. R,. - p¡€parsdol¡
and üse of cl,.toplamlc entiger¡s Jo.r the serodiagDosis of pÉcoccidiodoE¡ycosis. J. cltn. tttrüobtot., 22: 39-f3,
ALBORNOZ, M. B. & CABR{L, N. A. -
paÌåcocci-dioidoEicosis. Estudio cllnico ê i¡EÌrnol,óglco en 40
pacle¡t€€. ,A¡ch. Hosp. VarBas (Ver€zuera), rE: 5.22, 1976.
.A-RCIIAV¿LA, Á.; ROBLES, A. M.; ¡'INI(ELIEI¡ICH, J.
& NEGRONI, E. - Estuauo l¡mDológico €n pscie¡tes
po¡têdoler ale rmcosis sistémlcas y las mc¡dlftcaciones prcducidas I'or êl tlêtarni€nto. Bol, Acad. M€d, (8.
al¡€s), 59: 59-ß,
1981-BLI]MM&,, S. O.; Já.LBEBT, M. & K/IIIEIIAN, L. _
RBpid snd æl¡abie Eethod for p¡odl¡ctio ot s sp€cjjic
ll.
t2.
NEGRONI, R. - Nuevos sstudllos soble åatfg€¡os på¡¿
la9 p¡u€Das s,€Eológlcss en ls blsstomicosis
su¿L¡eÊlt-cåra. IÞ¡m. ttero L¡t. ¿mer., 4: 4109-461, $64.
NEGI¡ONI, Iù.; IOVáNNITTI DE FIORES, C. &
EOBLES, .6,. M. - Estudio ds tas ¡eacciones seloló-g¡cås cru,a¡¡as €Dtre aDtlC€Eos de p. blasl¡teÉ¡s y g.
carßr¡latum" R¿y. ÂBoc. srgEnt. Mlcroblot., t: 68-?3,. 19?6.
PÁL¡4ER, D. f. {. CAVÂI,I,ARO, J. J. - SoE_e concepts
of q$lity conhol ln iEmurossÌoloEy. I!: ROSE, N.
E. & ¡RIEDMAN, E. ed. - M¡[u¿l of cü¡¡c¡l lD;u.
CÀNO, L. E, & RES'I?EPO, A. - Ptecllctive value ol a€Eologlc tests tr¡ the di¿g¡osls and follqw.up of trlati€ûls \rttb ps.r3¿occidioidor¡J'côsiE, Rev. IDst, Med. trolr. São Pe[lo, nr nÈn3, rß87.
¡oloFr. lErashingtoD.
^4rûêrlcan Soclety fo! Microbiology,
19Ì6, p. 9i)6.910.
RESIREPO, Â. & MONCAÐÄ, L. E. - SercIogic pro. ceduEs ln tlìe aüagrosis of ps,mcoccidioialomycosis. I¡:
I¡['rmN,[fiON¡I SYMPOSIUM ON i\rtYCOSES.
Proc€êd-ings. Wa.Ebi¡gton, P¿HO, 1970, p. lol'110. (Scient. P¡¡til.
No.205).
R.ESTRE?O. Ä. & MONcÄDA, L. E. - Chaúcbâlzation
of thê pÌectpltià trallals aletected iû the iEmu¡odliffusloÀ tests fo! paracoccia¡¡oido¡lycoÂLs: Äppl. nflc¡oblol., i¿,8: 138.144, 19?4.
&ESTR.EPO, ,4.; RESTÞEO, M.; RESTBEPO, F.; ÂRI$ TIZAB¡J¿ L-t MONCÂDA, !. E. & I¡ELEZ, E. -tu]mü¡e rcsponse iD p8,lacocci¿holdoDrycogla: a con
ÈoUed study o¡ 16 p¿tielts befo¡ô aD¿l afte? tl€€lment. S¿boulsudiå. 16: 151-103, 19??.
RESTR@O, A. & C,AÌ'IO, L- E. - A comparison ol myceual fllbate and t€âsü lysÊte ps¡acoccidioidin in ¡)atfents wiüh ps,ÉcoccldioldoÈrycosis. MJcolrÃthologl¡
(De¡ u8.¿r), 84: 49-54, 1983.
R,ESTREPO, A.; GOMEZ, I.; C,åNO, L. E.; -ARANGO, M. D.; GIIIIEEREZ, P.; SANIN, A. & ROBLEDO, M.
Ä. - Îleatment of pÂracocclodioidomycosis çlth keto.
conåzole. A thlee-yea! erped€Ece. ame!. J. M€d,, 7iI
(18): 48-52, 1983.
EESIEEO,
^.i GO\EZ, I.; CÄNO, L, E-; 'AR¡NGO, M. D.; cmItRREz, F.; SANIN, ¿{. & RoBLÐo, M.
l7-19.
.á.. - Post-theBpt¡ st¿fuE of p$acocciauoidorrycosig
patiênts tæated with &etocor¡åzole. Áûer. J. llle¡l., !l
(18): 53-5?, 1983.
a.ESTREPO,4. - Procedimie¡tos serclógicos eÈ ¡a pùacoccialloidoEicosis. Aal€tmtos Microblol. E¡le!û.
lnl€o. 3: l834ll, 1984.
ROBLEDO, I\[. A.; GOMEZ, I.; GI'IIE&REZ, F.; CÁNC. L. E. & &ESTR.trO, A. - tvaluación s l¡go plauo
de pacie¡bes con paÉcoccr¿Uoidlo¡dlcoa¡s batÂdos cor
&etoconarol, Aot¡ Eed. oolomb., ü: 155-160, 1985.
RUBINSÌEIN, P, & NEGRONI, R,, €d. - Micosig bro¡coI)ulrnoùa¡es del adr¡lto y del Diño. Buenoa á,i!eÉ,
Editolial BetÈ, 1981. p. 1%.150;193-221.
WHEAT, J.; FRENCH, M. L, V,; KåMEL, S, &
Tglr9¡ÌI, R. P- EvaluâtloÈ oI crosÊ.rcactioDs ià R.
calÉ!t¡3!E selologic tesis. J, cII¡. Mlclobiol., 23: 493-499, 1986.
YARZ,IBAL, L. .4.; ALBORI{OZ, M.; CABRÁL, lf. tt ¡ S.A¡ÍrIÁGO, A. R. - Specülc double dlftussioD ûlcro
t€chnique fü the diagnæts of Àspe¡glllosls snd
pBrs-coccidroidomycosis usiDg üonospecütc aDttseE. Ssbou. lauaua, 16: 55-62, 19?8.
YÁRzllL¡iL, I". - Composición aÃtigé[ics de P. h!¡.
sili€Dsls, In: DEL NEGBO, G.i L.LCAZ, C. S. & F'IG 8.
.
25.
26.
n.
RILI,o, A. }I., ed.
-f¡r¡cose srd-aEeÌic€nB. Sáo Psdo, SaÍior;
1982. p. 59-67.
R€cebido para pl'lbllcadãô ú.